October 1, 2018 (Vol. 38, No. 17)

The Binding Site

Introducing a new series of affinity-purified, unconjugated, anti-human antibodies to the IgG subclasses, including IgG1, IgG2, IgG3, and IgG4. All of these polyclonal antibodies have been expressly designed for in vitro research use procedures as an integral component in solid- phase enzyme immunoassay based test methods, especially ELISA’s, as well as in other potential testing applications. These antibodies are of benefit to the needs of biopharmaceutical, clinical, and life science researchers, along with other allied health professionals and IVD manufacturers. All of the antibodies exhibit both high levels of purity and lot-to-lot consistencies while demonstrating outstanding degrees of specificity. In addition, all feature a long shelf-life stability claim and are available in standard fill formats of 0.5 mg/mL unitized-sized vials.

Previous articleChronic Back Pain Linked to Three Genetic Variants
Next articleNovel Method Improves Imaging and Progression of Atherosclerotic Plaque